by Nathaniel Harding | Jan 22, 2024 | Media
FOR IMMEDIATE RELEASE Jan. 16, 2024 Contact: Anthony Triana atriana@saxum.com (Direct) 405.818.0791 Cortado Ventures Invests in CorriXR: A Groundbreaking Gene-Editing Company with Initial Focus on Oncology OKLAHOMA CITY – Cortado Ventures, a...
by Nathaniel Harding | Jan 19, 2024 | Media
Congratulations to our Managing Partner, Nathaniel Harding for earning another term of service for the Greater Oklahoma City Chamber board. Board members, in roles like this, play a pivotal part in shaping the direction and policies of the organization....
by Nathaniel Harding | Jan 4, 2024 | Blog
Preclinical biotechnology company initially focusing on therapeutic drug development to promote remyelination in Multiple Sclerosis OKLAHOMA CITY, Dec. 14, 2023 /PRNewswire/ — Cadenza Bio, Inc. (Cadenza), a privately-held biotechnology company focused on...
by Nathaniel Harding | Dec 12, 2023 | Podcasts
ayer-v2/?i=xn586-1064b01-pbblog-playlist&pbad=0&share=1&download=1&rtl=0&fonts=Tahoma&skin=f6f6f6&font-color=auto&logo_link=episode_page&order=episodic&limit=2&filter=publish_time&publish_start=&publish_end=&ss=ab3b512276a86ad98d549245128ee5f3&btn-skin=ff6d00&size=220"...
by Nathaniel Harding | Dec 4, 2023 | Partner Articles
For media inquiries, please contact: Graham Spence, Vice President Sales gspence@geomarkresearch.com GeoMark Research and Senslytics Forge Strategic Partnership to Pioneer Breakthroughs in Artificial Intelligence Solutions Houston, Dec. 4, 2023 — GeoMark Research,...
